• Persistent itching without obvious rash
• Can severely impact sleep and quality of life
o "Uraemic pruritus," especially in dialysis patients
o Worse on palms and soles, may precede jaundice (e.g., PBC, PSC, intrahepatic cholestasis of pregnancy)
o Hodgkin lymphoma (classically worse after hot baths/alcohol)
o Polycythaemia vera (aquagenic pruritus)
• Iron deficiency anaemia
• Thyroid disorders
o Both hyper- and hypothyroidism
• Diabetes mellitus
o Especially in poorly controlled patients
• Drug-induced (e.g., opioids, hydroxychloroquine)
• Paraneoplastic syndromes
• Individual lesions usually resolve within <24 hours without scarring
Triggers
• Allergens: foods (nuts, shellfish), drugs (penicillins, NSAIDs)
o Cold (cold urticaria)
o Pressure (delayed-pressure urticaria)
o Heat or exercise (cholinergic urticaria)
o Sunlight (solar urticaria)
• Infections: viral URTIs (common in children)
• Defined as persisting >6 weeks
• Often idiopathic
• Can be autoimmune (autoantibodies to FcεRI on mast cells)
• First-line: non-sedating antihistamines (e.g., cetirizine, loratadine)
• Increase dose up to fourfold if needed
• Corticosteroids: short course for severe flares
• Omalizumab: for severe chronic cases unresponsive to antihistamines
• Brownish macules or papules → urticate on stroking (Darier’s sign)
• Due to local mast cell degranulation
• Flushing, pruritus, anaphylaxis, GI symptoms
• Increased serum tryptase
• Skin biopsy: dense mast cell infiltrates
• KIT mutation (c-KIT)
• Avoid triggers (e.g., NSAIDs, opioids, alcohol)
• Antihistamines, mast cell stabilisers (e.g., ketotifen)
• Epinephrine autoinjector if risk of anaphylaxis
Extra Revision Pearls
• Aquagenic pruritus: consider polycythaemia vera (JAK2 mutation)
• Darier’s sign: highly suggestive of mastocytosis
• Urticaria + systemic symptoms (e.g., hypotension, wheeze): think anaphylaxis → IM adrenaline
• Chronic urticaria rarely associated with systemic disease (unlike pruritus)
————————————————————————————————————————————————————————————————————————————————————————————————————————-
Author & Educational Disclaimer
Author:
Dr Phillip Cockrell BM FRCP DipClinEd
Dr Phillip Cockrell is a UK Consultant Physician in Internal Medicine, currently working at Queen Alexandra Hospital, Portsmouth University Hospitals NHS Trust. He has previously worked as a registrar across Intensive Care Medicine, Gastroenterology, Cardiology, Stroke Medicine, Acute Medicine, and Respiratory Medicine.
He has held senior leadership roles including Associate Clinical Director of the Acute Medical Unit, Clinical Director of Internal Medicine, and Chief of Medicine. Dr Cockrell has over 15 years’ experience in postgraduate medical education, having lectured extensively across the MRCP syllabus and contributed to MRCP revision teaching and course development.
Dr Cockrell holds a Bachelor of Medicine (BM), Fellowship of the Royal College of Physicians (FRCP), and a Diploma in Clinical Education (DipClinEd). His teaching approach is based on structured consolidation of complex medical topics to support efficient and effective revision for postgraduate examinations.
Purpose of this content:
The material on this page is intended solely for educational purposes to support revision for the MRCP (UK) Part 1 examination. It reflects examination-relevant principles of internal medicine and is designed to aid learning and pattern recognition.
Medical disclaimer:
This content is designed for postgraduate medical examination revision and does not constitute medical advice, diagnosis, or treatment guidance and must not be used as a substitute for professional clinical judgement, local guidelines, or specialist consultation. Clinical decisions should always be made in the context of individual patient circumstances and current national guidance.